Prof. Collen Masimirembwa founded and leads the African Institute of Biomedical Science and Technology (AiBST) as President & CEO. He currently serves as President of the African Pharmacogenomics Consortium (APC), Chief Scientific Officer at CradleOmics, and Distinguished Professor of Health Sciences at the University of Witwatersrand’s Sydney Brenner Institute for Molecular Biosciences in South Africa.

His research focuses on pharmacogenetics and clinical pharmacology, and he demonstrated the clinical relevance of Africa’s genomic diversity, particularly regarding the safe use of anti-retroviral drugs. He is a Fellow of the Zimbabwe Academy of Sciences and the African Academy of Sciences, and has received numerous awards, including the HUGO Africa Award (2018).

Prof. Masimirembwa studied at the University of Zimbabwe and earned his PhD at the Karolinska Institute, Sweden. He then worked at AstraZeneca Pharmaceutical Company as a Principal Scientist for about 10 years before returning to Africa.